News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Australia
Job Trends
AstraZeneca PLC Sold Its U.S. HQ But Will Spend $100 Million Expanding Its Australia Facility
July 12, 2017
·
1 min read
BioMidwest
BioPharm Executive: And So It Continues: Let’s Get Rid of Clinical Trials (Part 2)
July 7, 2017
·
4 min read
Drug Development
Bionomics Limited: A Company With Deals On The Horizon
July 5, 2017
·
1 min read
Genetown
5 Easy Steps To Generating Quick Job Referrals
July 4, 2017
·
1 min read
Genetown
The 3 Most Desirable Skills In The ‘New Breed’ Of Pharma Sales Reps
July 4, 2017
·
1 min read
Genetown
‘High Tech’ And Its Impact On Life Science Job Seekers
July 4, 2017
·
1 min read
Lone Star Bio
How To Be An Unforgettable Job Applicant
July 4, 2017
·
1 min read
Genetown
Avoid These 3 Networking Mistakes Every Unemployed Scientist Makes
July 4, 2017
·
1 min read
Biotech Bay
What Matters Most to Life Sciences Professionals?
The opportunity to do interesting and meaningful work is more valuable than money. That’s the consensus of more than 2,400 life science professionals according the 2017 Ideal Employer survey.
July 2, 2017
·
3 min read
·
Jennifer Fink
Biotech Bay
3 Under-the-Radar Biotech Clusters for Life Science Job Seekers
June 30, 2017
·
6 min read
PRESS RELEASES
Press Releases
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
December 24, 2025
·
2 min read
Press Releases
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
December 23, 2025
·
3 min read
Press Releases
Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study
December 23, 2025
·
5 min read
Press Releases
Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal
December 23, 2025
·
4 min read
Press Releases
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
December 22, 2025
·
11 min read
Press Releases
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
December 19, 2025
·
8 min read
Press Releases
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
December 17, 2025
·
9 min read
Press Releases
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
December 17, 2025
·
4 min read
Press Releases
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution
December 16, 2025
·
3 min read
Press Releases
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
December 15, 2025
·
5 min read
Press Releases
Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial
December 15, 2025
·
4 min read
Press Releases
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
December 12, 2025
·
4 min read
Press Releases
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
December 11, 2025
·
6 min read
Press Releases
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib’s Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
December 10, 2025
·
9 min read
Press Releases
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
·
13 min read
Press Releases
AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies
December 9, 2025
·
4 min read
Press Releases
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies
December 8, 2025
·
7 min read
Press Releases
Key Narmafotinib Patent Granted in the U.S.
December 4, 2025
·
2 min read
Press Releases
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer
December 3, 2025
·
4 min read
Press Releases
CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation
December 3, 2025
·
5 min read
